Published on 25/12/2025
How to Build and Maintain a Historical Site Performance Database
Introduction: The Strategic Importance of a Site Performance Repository
Feasibility evaluations are often performed in silos, with site performance data stored in spreadsheets, disconnected CTMS modules, or forgotten folders. This short-term thinking results in repetitive qualification efforts, missed insights, and increased risk during site selection. A well-structured historical site database provides sponsors and CROs with a long-term, centralized repository of investigator experience, compliance trends, and enrollment metrics across multiple trials and regions.
Whether built internally or using commercial platforms, a historical site performance database allows sponsors to identify pre-qualified sites quickly, avoid repeated mistakes, and generate inspection-ready documentation on past feasibility decisions. This article provides a step-by-step guide to creating such a database, ensuring regulatory alignment and operational efficiency.
1. Core Components of a Historical Site Database
A comprehensive database should include the following key elements:
- Site Identifiers: Site name, address, country, unique site ID, associated institution
- PI and Sub-I Information: Full CV, GCP training dates, therapeutic experience
- Trial Participation History: Protocol number, indication, phase, study start/end dates
- Performance Metrics: Enrollment vs. target, deviation rates, dropout rates, data query resolution
- Audit and Inspection History: Sponsor QA audits, regulatory findings,
Each of these should be standardized using controlled fields to ensure consistency and enable dashboard reporting or automated scoring.
2. Choosing the Right Platform and Architecture
Your site database can be built using different levels of complexity:
- Basic: Excel or Google Sheets with version control and access restriction
- Intermediate: Custom SharePoint site with filters, sorting, and form-based entries
- Advanced: Integrated with CTMS, using APIs and relational database models (e.g., PostgreSQL, Oracle)
Organizations with large global trials should aim for CTMS-level integration or data warehouse models to ensure scalability and security. Ensure that user access, audit trails, and backup processes are validated per regulatory requirements.
3. Standardizing Data Fields and Taxonomies
Consistency is critical. Each record should follow a defined structure using dropdown menus, validation rules, and unique site IDs. Suggested fields include:
| Field | Type | Example |
|---|---|---|
| Site ID | Text/Unique | SITE_00123 |
| Protocol Number | Text | ABC-2024-001 |
| Indication | Dropdown | Oncology, Rheumatology, etc. |
| Enrollment Target | Numeric | 25 |
| Subjects Enrolled | Numeric | 21 |
| Deviation Rate | Percentage | 5.5% |
| Last Audit Date | Date | 2023-06-15 |
| Audit Result | Dropdown | No findings, Minor, Major |
This structure enables easy filtering, benchmarking, and integration with feasibility dashboards or machine learning tools.
4. Data Sources and Import Strategy
Populating your historical database requires gathering data from multiple systems:
- CTMS: Monitoring reports, visit logs, enrollment stats
- EDC: Query logs, deviation reports, visit adherence
- eTMF: Site documents, training logs, audit reports
- Regulatory systems: Inspection results, IRB correspondence
- Feasibility tools: Historical questionnaire responses
Data should be imported with metadata and timestamps. Use unique keys (e.g., protocol number + site ID) to prevent duplication. Use ETL tools or APIs to automate data pulls where possible.
5. Creating Site Scorecards and Dashboards
To extract value from the database, build visual dashboards and scoring systems. These tools can help prioritize sites based on performance and risk.
Example: Site Quality Scorecard
| Metric | Weight | Score (0–10) | Weighted Score |
|---|---|---|---|
| Enrollment Performance | 30% | 8 | 2.4 |
| Protocol Deviation Rate | 25% | 9 | 2.25 |
| Audit History | 25% | 10 | 2.5 |
| Query Resolution Time | 20% | 7 | 1.4 |
| Total | 100% | – | 8.55 |
Sites scoring >8.0 may be automatically included in future pre-selection lists.
6. Regulatory Considerations for Site Databases
Maintaining a historical performance database has regulatory implications:
- All records must be version-controlled with full audit trails
- Data must be attributable, legible, contemporaneous, original, and accurate (ALCOA)
- Any scoring or ranking algorithms should be documented in SOPs
- Database access must be role-based with documented training
- Regulatory bodies may request to review feasibility justifications stored in the database
The database should be listed in the TMF index if used for final site decisions or monitoring plans.
7. Use Case: Building a Global Oncology Site Library
A mid-sized sponsor running global oncology trials implemented a historical site performance repository integrated with its CTMS. Over 500 sites were added over two years with 35 key performance indicators tracked. The outcome:
- 40% reduction in time spent on new feasibility cycles
- Pre-screening of high-risk sites using deviation and audit filters
- Centralized access for feasibility, monitoring, and regulatory teams
- Positive feedback from FDA inspectors during sponsor GCP audit
8. Maintenance and Governance
Maintaining a high-quality database requires ongoing governance:
- Assign database owners and access managers
- Update records after each closeout visit or audit
- Archive inactive sites after defined periods (e.g., 5 years)
- Conduct quarterly quality checks on data integrity
- Train all users on data entry standards and privacy compliance
Regular audits of the database structure and access logs should be part of the sponsor’s QMS plan.
Conclusion
Building a historical site performance database is no longer a luxury—it’s a strategic imperative for sponsors and CROs managing multiple trials. By centralizing feasibility and compliance data, sponsors can accelerate site selection, reduce operational risk, and meet growing regulatory expectations. When well-designed and properly maintained, such databases become invaluable tools across feasibility, clinical operations, QA, and regulatory functions—driving consistency, quality, and speed across the entire clinical development lifecycle.